A B S T R A C T Although recent studies suggest that interferons can increase the number of IgG Fc receptor (FcR'y) sites on mouse macrophages, direct assessment of similar effects on human mononuclear phagocytes is lacking. We therefore measured the specific binding of 125.-and fluorescein-labeled IgGl to human monocytes and leukemic cell lines after culture in vitro with highly purified human interferons. We report that natural and recombinant human 'y-interferon causes a dramatic (nearly 10-fold) increase in the number of FcR-y on normal human monocytes and on the human cell lines HL-60 and U-937. Alpha and ,B-interferons cause a modest but significant increase in these receptors. This report demonstrates that 'v-interferon acts directly on human mononuclear phagocytes to increase FcR-y sites, it identifies a qualitative difference in the physiologic actions of human type I and type II interferons, and it suggests that HL-60 and U-937 cells will be important models for further study of the molecular mechanisms of interferon action. The results reported here could also be the basis for a bioassay to assess the pharmacokinetics and variability of '-interferon action on monocytes of individual patients during treatment in vitro and in vivo.
INTRODUCTION Receptors for the Fc portion of IgG (Fc receptors or
FcR'y)l are important for normal mononuclear phagocyte functions including clearance of immune comReceived for publication 13 April 1983. ' Abbreviations used in this paper: FcR-y, receptors for the Fc portion of IgG; FITC, fluorescein isothiocyanate.
plexes (1) , phagocytosis (2) , antibody-dependent cellular cytotoxicity (3) , and tumoricidal actions in vivo of monoclonal antibodies (4) . FcRy probably also play FcRy. 1 X 107 monocytes were cultured for 48 h in 120-ml teflon vessels (Scientific Specialties, Randallstown, MD) in 10 ml of RPMI (8), and murine a-interferon has similar activity (9) . The augmentation of human monocyte FcR'y, which we have described (10) , is one of the largest lymphokine-induced macrophage activation effects reported to date (11) . During purification of the "Fc receptor-augmenting factor" we noted many physicochemical similarities to immune ("y) interferon, and we now show that human -y-interferon is a potent Fc receptor-augmenting factor, which probably accounts for the activity we identified in crude lymphokine preparations. METHODS Cells. HL-60 and U-937 cells (gifts of Dr. R. Gallo, National Cancer Institute, and Dr. P. Ralph, Sloan Kettering Institute, respectively) were cultured in RPMI 1640 (KC Biological, Inc., Lenexa, KS) plus 10% fetal bovine serum (Sterile Systems, Inc., Logan, UT). Human monocytes were obtained by adherence to plastic (7) and subsequent release by incubation for 2 h at 4°C. These cultures contained 84-94% monocytes as determined by morphology and specific staining with monoclonal antibody 63D3 (12) .
Analysis of Fc receptors. We (10) and others (13) have characterized Fc recelptors on human monocytes, HL-60 cells (14) , and U-937 cells (15) (10, 14) . Fluorescein isothiocyanate-labeled IgGI (FITCIgGl; fluorescein/protein ratio 3.8) was prepared according to Goding (17 cell was determined as previously described (14) . Human monocytes were stained and analyzed by flow cytometry as described. Fig. 2 shows the response to a-(A), #-(A), and 'Y-(-) interferon for U-937 cells ( 
